Pan Long, Yong Zhang, Yuk Kim Sun, Hoon Kim Young, Yuedong Shi, Xu Jianwei
Department of Plastic and Reconstructive Surgery, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai, 200032, China.
Aesthetic Plast Surg. 2016 Feb;40(1):157-63. doi: 10.1007/s00266-015-0580-y. Epub 2015 Oct 30.
Freeze-dried platelet-rich plasma (FD PRP) is of potential value for clinical applications. However, growth factors released from FD PRP have not been well studied. Our study investigates growth factor release from FD PRP preparations, compared with other PRP samples, to further facilitate such clinical use.
We used four experimental groups: (1) Fresh porcine PRP (PRP), (2) PRP activated by calcium chloride (CaCl2) (Ca PRP), (3) PRP activated by CaCl2, followed by freeze drying (Ca-FD PRP), and (4) PRP freeze-dried first, then activated by CaCl2 (FD-Ca PRP). All FD PRP samples were kept for up to 4 weeks at room temperature (22 °C) and reconstituted prior to analysis. Transforming growth factor-β1 (TGF-β1), platelet-derived growth factor AB (PDGF-AB), and vascular endothelial growth factor (VEGF) were quantitated by ELISA at 15 min and 1 h incubation times.
The concentrations of all growth factors in Ca PRP, measured at 1 h, were significantly higher than those in PRP (p < 0.05). PDGF-AB concentrations in FD-Ca PRP were not significantly different than in Ca PRP (p > 0.05). Levels of VEGF in Ca-FD PRP were not significantly different than in Ca PRP (p > 0.05). However, TGF-β1 concentrations in Ca-FD PRP, measured at 15 min, were higher than those in Ca PRP (p < 0.05).
PRP was activated efficiently by calcium chloride. Freeze-dried PRP remained rich in growth factors after storage for 4 weeks at room temperature, indicating its ease of use and wider possibilities for clinical applications.
This journal requires that authors assign a level of evidence to each submission to which Evidence-Based Medicine rankings are applicable. This excludes Review Articles, Book Reviews, and manuscripts that concern Basic Science, Animal Studies, Cadaver Studies, and Experimental Studies. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
冻干富血小板血浆(FD PRP)在临床应用中具有潜在价值。然而,FD PRP释放的生长因子尚未得到充分研究。我们的研究调查了FD PRP制剂中生长因子的释放情况,并与其他PRP样本进行比较,以进一步促进其临床应用。
我们使用了四个实验组:(1)新鲜猪PRP(PRP),(2)氯化钙(CaCl2)激活的PRP(Ca PRP),(3)氯化钙激活后冻干的PRP(Ca-FD PRP),以及(4)先冻干再用氯化钙激活的PRP(FD-Ca PRP)。所有FD PRP样本在室温(22°C)下保存长达4周,并在分析前进行复溶。在孵育15分钟和1小时时,通过酶联免疫吸附测定法(ELISA)对转化生长因子-β1(TGF-β1)、血小板衍生生长因子AB(PDGF-AB)和血管内皮生长因子(VEGF)进行定量。
在1小时时测量的Ca PRP中所有生长因子的浓度均显著高于PRP中的浓度(p < 0.05)。FD-Ca PRP中的PDGF-AB浓度与Ca PRP中的浓度无显著差异(p > 0.05)。Ca-FD PRP中的VEGF水平与Ca PRP中的水平无显著差异(p > 0.05)。然而,在15分钟时测量的Ca-FD PRP中的TGF-β1浓度高于Ca PRP中的浓度(p < 0.05)。
PRP被氯化钙有效激活。冻干PRP在室温下保存4周后仍富含生长因子,表明其使用方便,临床应用可能性更大。
本期刊要求作者为每篇适用循证医学排名的投稿指定证据水平。这排除了综述文章、书评以及涉及基础科学、动物研究、尸体研究和实验研究的手稿。有关这些循证医学评级的完整描述,请参阅目录或作者在线指南www.springer.com/00266。